Honoring a leader in innate immunity
On June 5 in Berlin, Germany, School of Medicine researcher Ruslan M. Medzhitov, Ph.D., received the inaugural Else Kröner Fresenius Award, an international prize for distinguished immunology research created in 2012 by the Else Kröner-Fresenius-Foundation (EKFF), one of Germany’s largest philanthropic organizations. The award recognizes Medzhitov’s pioneering contributions to our understanding of the innate immune system, which mounts an immediate defense against infection and provides the
New alliance with Gilead Sciences is ‘transformative’
When Robert J. Alpern, M.D., dean of the School of Medicine, was asked recently to prepare a brief overview of the current state of drug discovery for a symposium at Yale’s West Campus, a familiar phrase came quickly to mind: “It was the best of times, it was the worst of times ...” It’s an apt description. On the one hand, we live in what some call the “post-Gleevec era,” a time when basic research conducted over decades is bearing fruit in the form of remarkably effective, targeted drugs.